A 21-year-old man was allegedly stabbed to death at a wedding function in Thane’s Shahapur area and his body dumped in a ...

LOS ANGELES, CA – Lilly Singh is back with another game-changer. The YouTube star-turned-entrepreneur has launched HYPHEN8, a media network built to help South Asian content creators thrive.

European Medicines Agency advisers said Friday that Eli Lilly’s Alzheimer’s disease treatment should not be approved, once again diverging from their U.S. counterparts. The Committee for ...

Among the many high-profile attendees, comedian and YouTube star Lilly Singh and Never Have I Ever actress Poorna Jagannathan stood out, bringing their signature energy and style to the event.

Eli Lilly has emerged as a popular growth stock thanks to its strength in the weight loss space. But the pharma giant also has an enormous opportunity in the Alzheimer's Disease market.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/ ...

Eli Lilly & Co. is adding Alzheimer’s disease resources to the online platform it launched a year ago to sell obesity, diabetes and migraine medicines. Patients will now be able to use ...

This week we're unfurling the dancefloor's 100 most essential tracks, with 20 jams per day. The term “dance music” may conjure visions of heaving clubs, packed festival tents and partying with ...

One recent Wednesday night in Atlanta, dozens of people gathered in a studio space armed with water bottles, hand fans, towels and an expectation to be in sync. There were hugs among the regulars ...

The main stage will host lively Bollywood dance and Zumba sessions, open to everyone. Sports enthusiasts can try their hand at football, basketball, badminton, archery and table tennis ...

Former Pentagon deputy press secretary Sabrina Singh said Defense Secretary Pete Hegseth’s messages in a Signal group chat about the Houthi attack have left her “absolutely floored.” ...

Eli Lilly and Company (NYSE: LLY) today announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the production of lipoprotein ...